As of 2025-07-08, the Intrinsic Value of Singapore Medical Group Ltd (5OT.SI) is 0.59 SGD. This 5OT.SI valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.40 SGD, the upside of Singapore Medical Group Ltd is 49.30%.
The range of the Intrinsic Value is 0.45 - 0.89 SGD
Based on its market price of 0.40 SGD and our intrinsic valuation, Singapore Medical Group Ltd (5OT.SI) is undervalued by 49.30%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 0.45 - 0.89 | 0.59 | 49.3% |
DCF (Growth 10y) | 0.55 - 1.10 | 0.72 | 83.5% |
DCF (EBITDA 5y) | 0.38 - 0.50 | 0.42 | 7.3% |
DCF (EBITDA 10y) | 0.49 - 0.68 | 0.56 | 42.6% |
Fair Value | 0.75 - 0.75 | 0.75 | 90.99% |
P/E | 0.43 - 0.53 | 0.49 | 23.0% |
EV/EBITDA | 0.34 - 0.47 | 0.40 | 2.0% |
EPV | 0.43 - 0.71 | 0.57 | 43.6% |
DDM - Stable | 0.23 - 0.62 | 0.42 | 7.5% |
DDM - Multi | 0.35 - 0.77 | 0.48 | 21.9% |
Market Cap (mil) | 192.21 |
Beta | 0.96 |
Outstanding shares (mil) | 486.61 |
Enterprise Value (mil) | 177.73 |
Market risk premium | 5.10% |
Cost of Equity | 7.35% |
Cost of Debt | 4.35% |
WACC | 7.11% |